Wednesday, April 7, 2021

Nucleix Nabs $55M For Lung Cancer Detection

San Diego-based Nucleix, a startup which is developing liquid biopsy technology for early detection of lung cancer, has raised $55M in a funding round, the company announced this morning. The company said the funding was led by RA Capital Management, and also included BlackRock, Lilly Asia Ventures, LYFE Capital and MILFAM, plus OrbiMed, Aurum Ventures,

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---